India CRISPR Market (2025-2030)
The India CRISPR Market was valued at $58.5 Million in 2025 and projected to reach to $105.5 Million by 2030, representing a compound annual growth rate of 12.5%. India's CRISPR market is poised for accelerated growth driven by substantial investments in biotechnology infrastructure and a rapidly expanding ecosystem of skilled researchers.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
India CRISPR Market Trends and Insights
- India is emerging as a significant hub for gene-editing research and therapeutic development within the Asia Pacific region, driven by increasing investments in biotechnology infrastructure and a growing pool of skilled researchers.
- The market in India benefits from lower operational costs, government support for life sciences innovation, and rising prevalence of genetic disorders requiring advanced treatment solutions. The forecast period through 2030 reflects India's accelerating adoption of CRISPR technology across research institutions, pharmaceutical companies, and contract research organizations.
- India's competitive advantage in cost-effective drug development and manufacturing positions the country as an attractive destination for global CRISPR-based therapeutic development.
- Regulatory frameworks in India are gradually evolving to support gene therapy commercialization, further catalyzing market growth and attracting both domestic and international stakeholders to invest in India's CRISPR ecosystem..
Key Market Statistics
- CAGR (2025-2030) 12.5% CAGR
- Market Size, 2025 ~USD 58.5 Million
- Forecast, 2030 ~USD 105.5 Million
- Country India
India CRISPR Market Overview
Market Valuation Growth :
India's CRISPR market is valued at $58.5 million in 2025 and is projected to grow to $105.5 million by 2030, representing an impressive 12.5% CAGR, outpacing the global average of 11.2%.
Biotechnology Infrastructure Expansion :
India is rapidly developing world-class biotechnology infrastructure with increased government funding and private sector investments, positioning the country as a key hub for gene-editing research and development in Asia Pacific.
Skilled Research Workforce :
India boasts a growing pool of highly skilled researchers and scientists specializing in CRISPR technology, supported by leading academic institutions and research centers driving innovation in therapeutic applications.
Therapeutic Development Pipeline :
Indian biotech companies are actively developing CRISPR-based therapeutics for genetic disorders, cancer, and infectious diseases, with several candidates in preclinical and early clinical stages of development.
India CRISPR Market Dynamics
- The country's cost-competitive advantage, combined with increasing government support for genomic research and precision medicine initiatives, positions India as an emerging leader in gene-editing innovation within the Asia Pacific region.
- Collaborations between Indian biotech firms and global pharmaceutical companies are expected to accelerate commercialization of CRISPR-based therapies. The market outlook remains highly positive with growing adoption of CRISPR technology across therapeutic development, agricultural biotechnology, and diagnostic applications.
- Regulatory frameworks are evolving to support clinical trials and commercialization, while increasing healthcare spending and rising prevalence of genetic disorders create substantial demand for innovative gene-editing solutions.
- India's competitive manufacturing capabilities and research excellence position it as a critical player in the global CRISPR ecosystem..
Related Ecosystem
Advanced Genetic Sequencing
- Polymerase Chain Reaction (PCR)
- Reagents
- Assay Kits
- Bioinformatics
- Flow Cytometry
- Thermo Fisher Scientific Inc.
- Illumina, Inc.
- Agilent Technologies, Inc.
- Qiagen N.V.
- Danaher Corporation
Key Takeaways
- India's CRISPR market is valued at $58.5 million in 2025 and is expected to grow to $105.5 million by 2030, representing a 12.5% compound annual growth rate.
- India is positioning itself as a cost-effective hub for CRISPR research and therapeutic development, attracting global biotech companies and research collaborations.
- Government initiatives and increased funding for biotechnology infrastructure are accelerating CRISPR adoption across India's research and pharmaceutical sectors.
- India's large patient population with genetic disorders and improving healthcare infrastructure create significant opportunities for CRISPR-based therapeutic commercialization.
CRISPR Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | GRNA SYNTHESIS & CELL LINE DEVELOPMENT (Service) |
| Forecast Period | 2025-2030 |
| Growth Rate | CAGR of 11.2% from 2025 to 2030 |
| Largest Segment | PRODUCT (Offering) |
| Market Size Base Year (Billions) | ~USD 3.22 (2025) |
| Revenue Forecast (Billions) | ~USD 5.47 (2030) |
| Segments Covered | Offering, Type, End User, Service, Application, Product |
India CRISPR Market Report Segmentation
6 segment dimensions are covered across the global market.
By Offering
- Product
- Products
- Service
- Services
By Type
- Crispr Kits & Enzymes
- Crispr Libraries
- Other Products
By End User
- Academic & Research Institutes
- Other End Users
- Pharmaceutical & Biotechnological Companies
- Pharmaceutical & Biotechnology Companies
By Service
- Grna Synthesis & Cell Line Development
- Other Services
- Screening & Validation
By Application
- Agriculture
- Drug Discovery & Development
- Other Applications
By Product
- Crispr Kits & Enzymes
- Crispr Libraries
- Other Products
INDIA: CRISPR PRODUCTS MARKET, BY END USER, 2023–2030
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ACADEMIC & RESEARCH INSTITUTES | 12.9 | 13.7 | 15.4 | 17.3 | 19.4 | 21.8 | 24.6 | 27.6 | 12.5 |
| OTHER END USERS | 17.7 | 18.8 | 21.1 | 23.7 | 26.5 | 29.8 | 33.5 | 37.6 | 12.3 |
| PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES | 18.4 | 19.6 | 22 | 24.9 | 28 | 31.6 | 35.7 | 40.3 | 12.8 |
| TOTAL | 49.1 | 52.2 | 58.5 | 65.8 | 74 | 83.2 | 93.7 | 105.5 | 12.5 |
INDIA: CRISPR SERVICES MARKET, BY END USER, 2023–2030
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ACADEMIC & RESEARCH INSTITUTES | 5.8 | 6.3 | 7.1 | 8.1 | 9.2 | 10.4 | 11.8 | 13.4 | 13.5 |
| OTHER END USERS | 6.5 | 7 | 7.9 | 8.8 | 9.9 | 11.1 | 12.4 | 13.9 | 12.1 |
| PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES | 7.8 | 8.5 | 9.6 | 10.9 | 12.3 | 14 | 15.9 | 18.1 | 13.6 |
| TOTAL | 20 | 21.8 | 24.5 | 27.8 | 31.4 | 35.4 | 40.1 | 45.4 | 13.1 |
Target Audience
- Biotech & Pharmaceutical Companies : Identify market opportunities, assess competitive landscape, and develop strategies for CRISPR product development, licensing, and commercialization in India's high-growth market.
- Venture Capital & Private Equity Investors : Evaluate investment opportunities in Indian CRISPR startups and biotech firms, with detailed market sizing, growth projections, and risk assessment for portfolio decisions.
- Government & Policy Makers : Understand market dynamics and research trends to inform biotechnology policy, funding allocation, and regulatory framework development supporting India's CRISPR ecosystem.
- Academic & Research Institutions : Benchmark research capabilities, identify collaboration opportunities, and understand commercialization pathways for CRISPR research programs and therapeutic development initiatives.
- Healthcare Providers & Hospitals : Stay informed on emerging CRISPR-based therapeutic options, clinical trial opportunities, and adoption strategies for precision medicine and genetic disorder treatment in India.
Reasons to Buy this Report
- High-Growth Market Opportunity : Capitalize on India's CRISPR market growing at 12.5% CAGR through 2030, outpacing global growth rates and offering significant expansion opportunities for biotech companies and investors.
- Emerging Hub Status : Gain insights into India's positioning as a key Asia Pacific hub for gene-editing research, with detailed analysis of infrastructure development, research capabilities, and competitive advantages.
- Investment & Partnership Landscape : Understand funding trends, government initiatives, and collaboration opportunities between Indian biotech firms and global pharmaceutical companies driving market expansion and commercialization.
- Therapeutic Pipeline Intelligence : Access comprehensive data on CRISPR-based therapeutic development in India across genetic disorders, oncology, and infectious diseases, including clinical trial status and commercialization timelines.
- Regulatory & Market Entry Strategy : Obtain actionable insights on India's evolving regulatory framework, manufacturing capabilities, and market entry strategies for launching CRISPR-based products and services.
Frequently asked questions
What is the current size of India's CRISPR market in 2025?
India's CRISPR market is valued at $58.5 million in 2025, reflecting growing investment in gene-editing technologies and research infrastructure across the country.
What is the projected market size for India's CRISPR sector by 2030?
India's CRISPR market is projected to reach $105.5 million by 2030, growing at a compound annual growth rate of 12.5% during the forecast period.
Why is India becoming a hub for CRISPR technology development?
India offers cost-effective research and development capabilities, a large pool of skilled scientists, government support for biotechnology, and lower operational costs compared to developed markets, making it attractive for CRISPR innovation.
What factors are driving CRISPR market growth in India?
Key drivers include increasing government funding for life sciences, rising prevalence of genetic disorders, growing pharmaceutical and biotech sector investments, and evolving regulatory frameworks supporting gene therapy development in India.
How does India's CRISPR market compare to the global market?
While India's CRISPR market grows at 12.5% CAGR, slightly outpacing the global rate of 11.2%, India represents a smaller absolute market size but is rapidly emerging as a significant regional player within Asia Pacific.
RESEARCH METHODOLOGY
The research study utilized a range of secondary sources, directories, and databases to gather important information for analyzing the global CRISPR market. In addition, extensive interviews were conducted with various primary participants, including key industry members, subject-matter experts (SMEs), C-level executives from leading market players, and industry consultants. These interviews helped obtain and verify qualitative and quantitative information, allowing for a comprehensive evaluation of the market's growth scenarios. The global market size was estimated through secondary research, using both top-down and bottom-up approaches, followed by data triangulation that incorporated insights from industry experts to determine the final market size.
Secondary Research
Secondary research was primarily utilized to identify and gather information for the technical, market-oriented, and commercial analysis of the CRISPR market. The sources consulted for this study included the Broad Institute, Innovative Genomics Institute (IGI), National Institute of Food and Agriculture, International Chromosome and Genome Society (ICGS), National Human Genome Research Institute (NHGRI), Asia Pacific Society of Human Genetics (APSHG), Genetics Society of America (GSA), European Society of Human Genetics (ESHG), Centers for Common Disease Genomics (CDDG), Center for Cellular and Molecular Biology (CCMB) in India, and the Department of Biotechnology (DBT) in India.
Additional secondary sources comprised academic journals, company websites, corporate and regulatory filings such as annual reports, SEC filings, investor presentations, and financial statements; business magazines and research journals; press releases; and various trade, business, and professional associations. These sources were also instrumental in gathering essential information about key market players, market segmentation related to industry trends, developments at the regional and country levels, and technology prospects.
The secondary data collected was analyzed to determine the global CRISPR market size, which was subsequently validated through primary research.
Primary Research
Extensive primary research was conducted after gathering foundational knowledge about the global CRISPR market through secondary research. We carried out several primary interviews with market experts from both the demand and supply sides. On the demand side, we interviewed professionals from the pharmaceutical and biopharmaceutical industries, as well as from contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs). On the supply side, we spoke with C-level and D-level executives, product managers, and marketing and sales managers from key manufacturers, distributors, and channel partners.
The primary interviews were conducted across six major regions: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Approximately 65% of the interviews involved supply-side participants, while 35% were with demand-side participants. This primary data was collected through questionnaires, emails, online surveys, personal interviews, and telephone interviews.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were utilized to estimate and validate the overall size of the CRISPR market. These methods were also extensively employed to assess the sizes of various subsegments within the market. The research methodology for estimating the market size includes the following steps:
CRISPR Market : Top-Down and Bottom-Up Approach
Data Triangulation
After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) is a revolutionary tool used to edit genes in a way that resembles traditional GMO techniques. The use of the Cas9 enzymes differentiates CRISPR from other forms of genetic modification. CRISPR edits and rearranges genes by cutting out the damaged or unwanted part of the DNA, allowing the remaining DNA to be rearranged in a new way.
The report comprehensively analyzes the CRISPR market, covering a wide range of products & services such as CRISPR kits & enzymes, CRISPR libraries, gRNA synthesis, cell line development, and screening & validation.
Key Stakeholders
- Genome editing/genome engineering product manufacturers
- CRISPR editing/genome engineering product manufacturers
- Suppliers and distributors of genomic instruments/systems and consumables
- Contract manufacturing organizations
- Pharmaceutical and biotechnology companies
- Diagnostic centers and medical colleges
- Contract research organizations
- Government associations and research institutes
- Regulatory authorities
- Business research firms
Report Objectives
- To define, describe, and forecast the CRISPR market by offering, product, service, application, end user (products market), end user (services market), and region
- To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall CRISPR market
- To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to five regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players and analyze their market shares and core competencies
- To track and analyze competitive developments, such as product/service launches, partnerships, agreements, collaborations, and expansions
- To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategy
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:
Portfolio Assessment
- Product Matrix, which gives a detailed comparison of the product/service portfolios of the top three companies.
Company Information
- Detailed analysis and profiling of additional market players (up to three).
Geographical Analysis
- A further breakdown of the Rest of Asia Pacific CRISPR market into countries
- A further breakdown of the Rest of Europe CRISPR market into countries
- A further breakdown of the Rest of Latin America CRISPR market into countries
Get the Full CRISPR Market Report
Full forecast, segment splits, and company analysis for all CRISPR Market.
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report